Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database

BACKGROUND/OBJECTIVES: Addition of cilostazol or sarpogrelate to the standard dual antiplatelet therapy of aspirin and clopidogrel has been implemented in patients that underwent percutaneous coronary intervention (PCI) with stents in Korea. This study aimed to evaluate the efficacy and safety of tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Noh, Yoojin, Lee, Jimin, Shin, Sooyoung, Lim, Hong-Seok, Bae, Soo Kyung, Oh, Euichul, Kim, Grace Juyun, Kim, Ju Han, Lee, Sukhyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777511/
https://www.ncbi.nlm.nih.gov/pubmed/26939062
http://dx.doi.org/10.1371/journal.pone.0150475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777511/
https://www.ncbi.nlm.nih.gov/pubmed/26939062
http://dx.doi.org/10.1371/journal.pone.0150475

Ejemplares similares